Overview

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Status:
Completed
Trial end date:
2006-09-21
Target enrollment:
Participant gender:
Summary
This is a multi-center, Phase III study to evaluate the safety and tolerability of proposed dose conversion recommendations for RLS subjects converting from ropinirole immediate release to ropinirole controlled-release for RLS.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole